FindTrial
Sign In

Study on the application effect of liuzijue qigong in early and middle stage patients with Parkinson's disease

The effect of Liuzijue qigong for patients with Parkinson's disease in early and middle stage : A randomized?single-blind ? controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056762
Enrollment
Unknown
Registered
2022-02-15
Start date
2022-02-15
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Experimental group:Liuzijue Qigong and routine home rehabilitation
Control group:Routine home rehabilitation

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with PD diagnosis criteria released by Parkinson's Disease and Movement Disorders Group, Chinese Society of Neurology in 2014, and hoehn-YahRPD grading standard was Grade I -III; 2. Can cooperate in training and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. A history of other diseases causing respiratory muscle damage; 2. Severe skeletal and spinal deformity; 3. Taking drugs (such as steroid hormones and immunosuppressants) that may affect muscle structure and lung function; 4. Patients with severe cognitive impairment; 5. Patients with concurrent pulmonary infection.

Design outcomes

Primary

MeasureTime frame
lung function;—

Secondary

MeasureTime frame
Motor function;neuropsychological;The quality of life;—

Countries

CHINA

Contacts

Public ContactOumei Cheng

The First Affiliated Hospital of Chongqing Medical University

chengoumei01@aliyun.com+86 131 0237 2730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026